ARCHIVES

NCI Internal Debate Ends With Move of Biometry Branch, Including SEER, From DCCP To DRCCA

This article is from The Cancer Letter archive.

Vol. 09 No. 36 | September 23, 1983

Download PDF Visit The Full Archive

Related Articles

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

In Brief: Bailes Elected President Of ASCO For 1999; Outlines Goals In Remarks To ACCC

March 20, 1998

NCI Clinical Trials Working Group is looking for pragmatic solutions to improve cancer clinical trials system, Institute official says.

September 24, 2004

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

Biopsy System Effective In Removing Benign Breast Masses, Study Finds

May 28, 2004

Drug Combination Tested For B.C. Brain Metastases

January 25, 2008